Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesotheliomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01521325
What this trial is testing

A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers

Who this might be right for
MesotheliomaPancreatic CancerOvarian Cancer+1 more
Morphotek 6
Testing effectiveness (Phase 2)Ended earlyNCT01861301
What this trial is testing

Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma

Who this might be right for
Epithelioid MesotheliomaRecurrent Malignant MesotheliomaSarcomatoid Mesothelioma+3 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT00066404
What this trial is testing

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

Who this might be right for
Cancer
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Looking for participantsNCT04665206
What this trial is testing

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

Who this might be right for
Solid Tumor, AdultMesotheliomaNSCLC
Vivace Therapeutics, Inc 434
Early research (Phase 1)Active Not RecruitingNCT04328844
What this trial is testing

Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

Who this might be right for
Solid Tumor, AdultNon-Hodgkin Lymphoma, AdultNSCLC+2 more
iOnctura 210
Not applicableStudy completedNCT01135849
What this trial is testing

B-Receptor Signaling in Cardiomyopathy

Who this might be right for
CarcinomasAmyloidosisAnal Cancer+35 more
Daniel Bernstein 99
Testing effectiveness (Phase 2)Looking for participantsNCT05944237
What this trial is testing

HTL0039732 in Participants With Advanced Solid Tumours

Who this might be right for
NeoplasmsProstatic Neoplasms, Castration-ResistantStomach Neoplasms+11 more
Cancer Research UK 150
Early research (Phase 1)Not Yet RecruitingNCT07713732
What this trial is testing

TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors

Who this might be right for
Small Cell Lung Cancer ( SCLC )Neuroendocrine CancerMalignant Pleural Mesotheliomas (Mpm)+1 more
Treeline Biosciences, Inc. 120
Testing effectiveness (Phase 2)UnknownNCT00685204
What this trial is testing

An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma

Who this might be right for
Mesothelioma
Taxolog Inc. 90
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Large-scale testing (Phase 3)Not Yet RecruitingNCT07824986
What this trial is testing

Trial in Advanced Epithelioid Mesothelioma

Who this might be right for
Pleural MesotheliomaMesothelioma
Vivace Therapeutics, Inc 350
Testing effectiveness (Phase 2)Ended earlyNCT03233724
What this trial is testing

Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas

Who this might be right for
Carcinoma, Non-Small-Cell LungLung CancerNon-Small Cell Lung Cancer+2 more
National Cancer Institute (NCI) 9
Not applicableEnded earlyNCT00028782
What this trial is testing

EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer

Who this might be right for
Advanced Malignant MesotheliomaLocalized Malignant MesotheliomaMalignant Ascites+2 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07705074
What this trial is testing

FAPI PET Imaging - An Exploratory Study

Who this might be right for
Thyroid PathologyHead and Neck Cancer (H&N)Sinonasal Tract Tumor+14 more
Martin Huellner 770
Not applicableStudy completedNCT01773655
What this trial is testing

Clinical and Histopathologic Characteristics of BAP1 Mutations

Who this might be right for
Malignant Pleural Mesothelioma (MPM)Choroidal NevusPrimary Uveal Melanoma (UM)+3 more
Memorial Sloan Kettering Cancer Center 196
Early research (Phase 1)Study completedNCT00629343
What this trial is testing

Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide

Who this might be right for
Soft Tissue SarcomaMesothelioma
Columbia University 27
Early research (Phase 1)Looking for participantsNCT05627960
What this trial is testing

First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

Who this might be right for
Triple Negative Breast CancerHormone-Resistant Breast CancerNon Small Cell Lung Cancer+1 more
A&G Pharmaceutical Inc. 77
Not applicableLooking for participantsNCT02073500
What this trial is testing

Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies

Who this might be right for
Pseudomyxoma PeritoneiColorectal CarcinomaOvarian Carcinoma+1 more
Oslo University Hospital 300
Early research (Phase 1)Study completedNCT00398138
What this trial is testing

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

Who this might be right for
LeukemiaLung CancerMalignant Mesothelioma+2 more
Memorial Sloan Kettering Cancer Center 22
Next Page